Text

Exploration of Methadone And HIV Treatment For Injecting Drug Users in West Java, Indonesia: Lessons From Practice

---

Over the last decade, lndonesia became one of the fastest growing injecting drug user (IDU) driven Human Immune Defeciency Virus (HIV) epidemics in Asia. Among strategies to prevent and control the HIV epidemic in lndonesia, methadone maintenance treatment (MMT) has been established and could become an entry point for HIV testing and treatment in IDUs. This study explored MMT and HIV treatment practices in West Java. An evaluation team visited six MMT cllntcs, interviewed staff and collected data on patient characteristics, methadone dose, and HIV testing and treatment practices. By October 2011, from 203 IDUs entering MMT (range 7-73 per clinic), 95% were male with the average age of 31 years (range 19-60 years), 92% had a senior high school or higher diploma, 47% had a regular income, and 55% were married. The mean methadone dose was 79 mg/day (range 13-208 mg/day). About 85% of the MMT patients were tested for HIV, of whom 70% were found HIV positive (121/173), while 59% had abaseline CD4 count > 200 cells/mm3 and 65% were receiving ART. In conclusion, few 'IDUs entered MMT in West Java and among those who did, high HIV and ART rates were reported, stressing the need for active linking between harm reduction services and integrated MMT and HIV treatment for IDUs. [GMHC,2012; (1): 4 - 8].
Key words: Injecting Drug User, Methadone, HIV, ART, Clinical Guideline, Indonesia

---

Availability

Detail Information

Series Title

-

Call Number

Global Medical Health & Communication : Journal of

Publisher

Bandung : FK Universitas Islam Bandung., 2012

Collation

5p

Language

ISBN/ISSN

2301-9123

Classification

-

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

HIV
AIDS

Specific Detail Info

-

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment